Older adults with major depressive disorder (MDD) demonstrate distinct and riskier driving behaviors than those withou ...

Here’s a look at the best and worst states in each of our four data categories: mental health provider ratio, percentage of ...

Sleep problems may be one of the first symptoms of major depressive disorder -- a serious, but treatable mental health problem, more commonly known as depression. Not only a symptom of depression ...

Depression, sometimes called major depressive disorder, can hurt your ability to think through even simple daily tasks. Doctors call this decline in thinking skills "cognitive impairment." ...

In this longitudinal cohort study of older drivers, adults with major depressive disorder demonstrated distinct and riskier driving ...

The changing landscape of health care during COVID-19 placed focus on increasing accessibility to mental health resources other than the emergency department (ED), with potential savings of over $ ...

TMS has been approved for treating clinical depression in adults since 2008. Recent effectiveness data with adolescents shows ...

White matter alterations within the brain are associated with cognitive impairment among individuals with and without major ...

Neumora Therapeutics to release phase 3 data on Navacaprant for MDD treatment in 2024. Check out NMRA's catalysts that might ...

Transcranial magnetic stimulation for alcohol use disorders is under investigation. Research to date suggests TMS could play ...

Nelivaptan (NB-415, SSR-149415) is under development for the treatment of depression including major depressive disorder (MDD). The drug candidate targets vasopressin receptor 1B ( (V1bR). It is ...

From 2017 to 2021, pediatric depression and anxiety rates increased by 55.6% and 31.1%, respectively. Rates were higher ...